Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Leukemia|March 8, 2019
Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signalingMaja Kim Kuepper, Marlena Bütow, Oliver Herrmann, et al.
Annals of Hematology|August 14, 2021
Early and late stage MPN patients show distinct gene expression profiles in CD34+ cellsJulian Baumeister, Tiago Maié, Nicolas Chatain, et al.
Virchows Archiv : an International Journal of Pathology|March 22, 2020
Comparative genomic profiling of glandular bladder tumoursAngela Maurer, Nadina Ortiz-Bruechle, Karolina Guricova, et al.
Microbial Biotechnology|May 16, 2021
SARS-CoV-2 RNA screening in routine pathology specimensSaskia von Stillfried, Sophia Villwock, Roman D Bülow, et al.
Annals of the New York Academy of Sciences|October 25, 2019
Comparison of flow-FISH and MM-qPCR telomere length assessment techniques for the screening of telomeropathiesMonica S Ventura Ferreira, Martin Kirschner, Insa Halfmeyer, et al.
Oncogene|September 26, 2020
EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancerMichael Rose, Angela Maurer, Julia Wirtz, et al.
Stem Cell Reports|October 22, 2021
CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytesKathrin Olschok, Lijuan Han, Marcelo A S de Toledo, et al.
Leukemia|May 12, 2018
Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenitaMartin Kirschner, Angela Maurer, Marcin W Wlodarski, et al.
Annals of Hematology|December 23, 2022
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study groupSteffen Koschmieder, Susanne Isfort, Dominik Wolf, et al.
Hemasphere|April 25, 2023
Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified CriteriaMareike Tometten, Martin Kirschner, Robert Meyer, et al.
Pageof 3